Allopathic Medications for Genes Cure
Allopathic medications play a vital role in managing genetic disorders by targeting symptoms and improving patient quality of life. At Genes Cure, we provide comprehensive information on effective medications that align with the latest medical advancements, helping patients and healthcare providers make informed decisions for optimal genetic health outcomes.
-
Levodopa/carbidopa: Used for Parkinson’s disease.
Brief information about it: Levodopa/carbidopa is a combination medication used to treat Parkinson’s disease, a neurodegenerative disorder that affects movement.…
Read More » -
Naglazyme: Used for Sanfilippo syndrome type A.
Brief information about it: Naglazyme is an enzyme replacement therapy (ERT) used to treat Sanfilippo syndrome type A, a rare…
Read More » -
Aldurazyme: Used for Hunter syndrome.
Brief information about it: Aldurazyme is an enzyme replacement therapy (ERT) used to treat Hunter syndrome, a rare genetic disorder…
Read More » -
Lumizyme: Used for Fabry disease.
Brief information about it: Lumizyme is an enzyme replacement therapy (ERT) used to treat Fabry disease, a rare genetic disorder…
Read More » -
Myozyme: Used for Pompe disease.
Brief information about it: Myozyme is an enzyme replacement therapy (ERT) used to treat Pompe disease, a rare genetic disorder…
Read More » -
Ceredase: Used for Gaucher disease.
Brief information about it: Ceredase is an enzyme replacement therapy (ERT) used to treat Gaucher disease, a rare genetic disorder…
Read More » -
Spark-101: Being developed for Leber congenital amaurosis (LCA) type 10.
Brief information about it: Spark-101, also known as voretigene nepavehvec-rzyl, is a gene therapy being developed for the treatment of…
Read More » -
OTC-601: Being developed for Huntington’s disease.
Brief information about it: OTC-601 is an investigational therapy being developed for the treatment of Huntington’s disease, a neurodegenerative disorder…
Read More » -
RGX-314: Being developed for Duchenne muscular dystrophy.
Brief information about it: RGX-314 is a gene therapy being developed for the treatment of Duchenne muscular dystrophy (DMD), a…
Read More » -
CORTEX-1: Being developed for cystic fibrosis.
Brief information about it: CORTEX-1 is a gene therapy being developed for the treatment of cystic fibrosis (CF), a genetic…
Read More »